Literature DB >> 11095819

Update on Hepatobiliary and Pulmonary Flukes.

.   

Abstract

Hepatobiliary and pulmonary trematodes continue to cause significant morbidity and mortality worldwide. This article provides a selected update on the clinical features, diagnosis, immunology, treatment, and control of infections caused by Clonorchis sinensis, Opisthorchis species, Fasciola hepatica, and Paragonimus species. Although recent molecular studies have elucidated novel mechanisms of immune evasion in Paragonimus westermani and F. hepatica, there are no immediate prospects for a vaccine for any of these trematodes. Although treatment of paragonimiasis, clonorchiasis, and opisthorchiasis was simplified with praziquantel in the 1980s, eradication of fascioliasis remains difficult because of the limited availablity of bithionol. Several experimental drugs have been tested as possible alternatives. Despite successful pilot public health programs designed to decrease transmission of these trematodes, their prevalence remains high and underlines the importance of allocating resources to control them.

Entities:  

Year:  1999        PMID: 11095819     DOI: 10.1007/s11908-999-0054-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  47 in total

Review 1.  Homing in on helminths.

Authors:  D R Hopkins
Journal:  Am J Trop Med Hyg       Date:  1992-06       Impact factor: 2.345

2.  Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the Northern Bolivian Altiplano.

Authors:  J G Esteban; A Flores; C Aguirre; W Strauss; R Angles; S Mas-Coma
Journal:  Acta Trop       Date:  1997-06-24       Impact factor: 3.112

3.  Field trials in the control of Opisthorchis viverrini with an integrated programme in endemic areas of northeast Thailand.

Authors:  S Saowakontha; V Pipitgool; S Pariyanonda; S Tesana; K Rojsathaporn; C Intarakhao
Journal:  Parasitology       Date:  1993-04       Impact factor: 3.234

4.  Immunosuppression by a neutral thiol protease from parasitic helminth larvae in mice.

Authors:  F Hamajima; M Yamamoto; S Tsuru; K Yamakami; T Fujino; H Hamajima; Y Katsura
Journal:  Parasite Immunol       Date:  1994-05       Impact factor: 2.280

5.  Albendazole in the treatment of opisthorchiasis and concomitant intestinal helminthic infections.

Authors:  S Pungpark; D Bunnag; T Harinasuta
Journal:  Southeast Asian J Trop Med Public Health       Date:  1984-03       Impact factor: 0.267

6.  Clinical study evaluating efficacy of praziquantel in clonorchiasis.

Authors:  B G Yangco; C De Lerma; G H Lyman; D L Price
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

7.  Treatment of human fascioliasis with niclofolan.

Authors:  T Eckhardt; H Heckers
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

8.  Fascioliasis--a large outbreak.

Authors:  E W Hardman; R L Jones; A H Davies
Journal:  Br Med J       Date:  1970-08-29

Review 9.  Fascioliasis in developed countries: a review of classic and aberrant forms of the disease.

Authors:  R Arjona; J A Riancho; J M Aguado; R Salesa; J González-Macías
Journal:  Medicine (Baltimore)       Date:  1995-01       Impact factor: 1.889

10.  Radiological findings of human fascioliasis.

Authors:  J K Han; B I Choi; J M Cho; K B Chung; M C Han; C W Kim
Journal:  Abdom Imaging       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.